|
CONSOLIDATED UNAUDITED
FINANCIAL RESULTS (PROVISIONAL) FOR THE PERIOD |
|
||||
|
ENDED 31st MARCH, 2007 |
|
|
(Figures
Rupees .in Lakhs) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Period ended |
|
|
|
|
|
|
31st March, 2007 |
|
|
|
|
|
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales |
|
|
|
|
16361.80 |
|
Other
Income |
|
|
|
|
409.43 |
|
Total
Income |
|
|
|
|
16771.23 |
|
Total
Expenditure |
|
|
|
|
|
|
a)
(Increase) /decrease in stock in trade. |
|
|
|
|
(174.39) |
|
b)
Consumption of materials. |
|
|
|
|
6031.62 |
|
c) Staff
Cost |
|
|
|
|
1409.31 |
|
d)
Advertisement and Sales Promotion |
|
|
|
|
1970.74 |
|
e) Other
expenditure |
|
|
|
|
4836.39 |
|
Interest |
|
|
|
|
55.02 |
|
Depreciation |
|
|
|
|
339.79 |
|
|
|
|
|
|
|
|
Profit
before Tax |
|
|
|
|
2302.75 |
|
|
|
|
|
|
|
|
Provision
for Taxation |
|
|
|
|
|
|
-- Current Tax |
|
|
|
|
607.31 |
|
-- Deferred Tax |
|
|
|
|
63.95 |
|
-- Fringe Benefit Tax |
|
|
|
|
44.41 |
|
|
|
|
|
|
|
|
Net
Profit before Minority Interest |
|
|
|
|
1587.08 |
|
Minority
Interest |
|
|
|
|
7.24 |
|
Net
Profit after Minority Interest |
|
|
|
|
1579.84 |
|
Paid-up
equity share capital |
|
|
|
|
806.40 |
|
(Face
value Rs.100/-) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
& Diluted EPS for the period (Rs) |
|
|
|
|
195.91 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate
of Public Shareholding |
|
|
|
|
|
|
(a)
Number of Shares |
|
|
|
|
468003 |
|
(b)
Percentage of Shareholding |
|
|
|
|
58.04% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note : |
|
|
|
|
|
|
1.The above
results were reviewed by Audit Committee and thereafter were taken on record
by the Board of Directors in their meeting |
|||||
|
held on 21st
April,2007. |
|
|
|
|
|
|
2.Consolidated
Financial results include the financial results of the subsidiary Zandu Chemicals Ltd.with effect
1 st November,2006 |
|
||||
|
being the date it has become a subsidiary Company.The sales revenue of Zandu
Chemicals Ltd for the year ended 31 st March,2007 |
|||||
|
was Rs.4516.72 lacs |
|
|
|
|
|
|
3.Earning
per share for the previous periods has been adjusted for the issue of Bonus
share in the ratio of 1:3 alloted on 20th |
|
||||
|
January,2007 as per Accounting Standard
20(AS 20) on Earnings per share |
|
|
|
||
|
4.The
Consolidated Financial Statements are prepared in accordance with the
Accounting Standard 21"Consolidated Financial Statements" |
|||||
|
issued by the |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Zandu
Pharmaceutical Works Ltd. |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Place :
Mumbai |
|
|
(Girish
Parikh) |
|
|
|
Date :
21 st April, 2007 |
|
|
Managing Director |
|
|